Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03637374 · ClinicalTrials.gov registry record · NA
Safety, Efficacy, Longitudinal Costs and Patient-Centered Outcomes Using a TAAA Debranching Device
A NA study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03637374: Clinical Trial NA study, sponsored by Johns Hopkins University.
NCT03637374 is a NA study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03637374, a NA study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The primary purpose of this study is to assess the use of the TAAA Debranching Stent Graft System to repair thoracoabdominal aortic aneurysms in patients having appropriate anatomy, as measured by device safety, effectiveness, costs of delivery of aortic surgery care, and patient quality of life domains. Additionally, the study will assess technical success and treatment success at each follow-up interval.
Interventions
- DEVICE Visceral Manifold and Thoracic Bifurcation
- DEVICE Unitary Manifold
- DEVICE TAAA Debranching Stent Graft System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2020-09-08 |
| Est. Completion | 2022-06-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03637374
The ClinicalTrials.gov registry entry for NCT03637374 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Visceral Manifold and Thoracic Bifurcation is the first listed.
NCT03637374 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03637374 about?
NCT03637374 is a clinical study titled "Safety, Efficacy, Longitudinal Costs and Patient-Centered Outcomes Using a TAAA Debranching Device". The primary purpose of this study is to assess the use of the TAAA Debranching Stent Graft System to repair thoracoabdominal aortic aneurysms in patients having appropriate anatomy, as measured by device safety, effectiveness, costs of delivery of aortic surgery care, and patient quality of life dom...
What is the current status of trial NCT03637374?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2020-09-08. Estimated completion is 2022-06-06.
What interventions are being tested in trial NCT03637374?
The interventions under investigation include: Visceral Manifold and Thoracic Bifurcation (DEVICE), Unitary Manifold (DEVICE), TAAA Debranching Stent Graft System (DEVICE).
Who is sponsoring clinical trial NCT03637374?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.